Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cr 605
1. 55837-29-1
2. Tiropramide [inn]
3. Cr-605
4. R7s0904cn2
5. Tiropramide (inn)
6. Benzenepropanamide, Alpha-(benzoylamino)-4-(2-(diethylamino)ethoxy)-n,n-dipropyl-, (+-)-
7. Tiropramida [spanish]
8. Tiropramida
9. Tiropramidum
10. Tiropramidum [inn-latin]
11. Tiropramida [inn-spanish]
12. N-(3-(4-(2-(diethylamino)ethoxy)phenyl)-1-(dipropylamino)-1-oxopropan-2-yl)benzamide
13. N-[3-[4-[2-(diethylamino)ethoxy]phenyl]-1-(dipropylamino)-1-oxopropan-2-yl]benzamide
14. (+/-)-tiropramide
15. Brn 4162600
16. Maioral
17. Tirospan
18. Unii-r7s0904cn2
19. O-(diethylaminoethyl)-n-benzoyl-dl-tyrosyl-di-n-propylamide
20. Tiropramide [mi]
21. Dl-alpha-benzamido-para-(2-(diethylamino)ethoxy)-n,n-dipropylhydrocinnamamide
22. (+-)-alpha-(benzoylamino)-4-(2-(diethylamino)ethoxy)-n,n-dipropylbenzenepropanamide
23. Schembl25693
24. Tiropramide [who-dd]
25. Chembl2104688
26. Dtxsid70866514
27. Chebi:135758
28. Akos015909639
29. Dl-alpha-benzamido-p-(2-(diethylamino)ethoxy)-n,n-dipropylhydrocinnamamide
30. Db13091
31. D07087
32. Q7809264
33. (+/-)-.alpha.-benzamido-p-(2-(diethylamino)ethoxy)-n,n-dipropylhydrocinnamamide
34. Dl-.alpha.-benzamido-p-(2-(diethylamino)ethoxy)-n,n-dipropylhydrocinnamamide
35. N-(2-{4-[2-(diethylamino)ethoxy]phenyl}-1-(dipropylcarbamoyl)ethyl)benzenecarboximidic Acid
Molecular Weight | 467.6 g/mol |
---|---|
Molecular Formula | C28H41N3O3 |
XLogP3 | 5.2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 15 |
Exact Mass | 467.31479218 g/mol |
Monoisotopic Mass | 467.31479218 g/mol |
Topological Polar Surface Area | 61.9 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 561 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
A - Alimentary tract and metabolism
A03 - Drugs for functional gastrointestinal disorders
A03A - Drugs for functional gastrointestinal disorders
A03AC - Synthetic antispasmodics, amides with tertiary amines
A03AC05 - Tiropramide
Regulatory Info :
Registration Country : Italy
Brand Name : Maiorad
Dosage Form :
Dosage Strength : 30 Cpr 100 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Alfospas
Dosage Form :
Dosage Strength : 30 Cps 200 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Global Sales Information
ROTTAPHARM SpA
Dosage Form :
Dosage Strength : 30 Cpr 100 Mg
Price Per Pack (Euro) : 8.9
Published in :
Country : Italy
RX/OTC/DISCN : Class C
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ROTTAPHARM SpA
Dosage Form :
Dosage Strength : 30 Cps 200 Mg
Price Per Pack (Euro) : 12.75
Published in :
Country : Italy
RX/OTC/DISCN : Class C
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?